Abstract
Shiga toxin-producing Escherichia coli bacteria cause hemorrhagic colitis and hemolytic uremic syndrome in humans. Currently, only supportive treatment is available for diagnosed patients. We show here that 24-h pretreatment with an ether lipid precursor, the alkylglycerol sn-1-O-hexadecylglycerol (HG), protects HEp-2 cells against Shiga toxin and Shiga toxin 2. Also the endothelial cell lines HMEC-1 and HBMEC are protected against Shiga toxins after HG pretreatment. In contrast, the corresponding acylglycerol, dl-α-palmitin, has no effect on Shiga toxicity. Although HG treatment provides a strong protection (~30 times higher IC50) against Shiga toxin, only a moderate reduction in toxin binding was observed, suggesting that retrograde transport of the toxin from the plasma membrane to the cytosol is perturbed. Furthermore, endocytosis of Shiga toxin and retrograde sorting from endosomes to the Golgi apparatus remain intact, but transport from the Golgi to the endoplasmic reticulum is inhibited by HG treatment. As previously described, HG reduces the total level of all quantified glycosphingolipids to 50–70 % of control, including the Shiga toxin receptor globotriaosylceramide (Gb3), in HEp-2 cells. In accordance with this, we find that interfering with Gb3 biosynthesis by siRNA-mediated knockdown of Gb3 synthase for 24 h causes a similar cytotoxic protection and only a moderate reduction in toxin binding (to 70 % of control cells). Alkylglycerols, including HG, have been administered to humans for investigation of therapeutic roles in disorders where ether lipid biosynthesis is deficient, as well as in cancer therapy. Further studies may reveal if HG can also have a therapeutic potential in Shiga toxin-producing E. coli infections.
Similar content being viewed by others
References
Bergan J, Dyve Lingelem AB, Simm R, Skotland T, Sandvig K (2012) Shiga toxins. Toxicon 60:1085–1107. doi:10.1016/j.toxicon.2012.07.016
Melton-Celsa A, Mohawk K, Teel L, O’Brien A (2012) Pathogenesis of Shiga-toxin producing Escherichia coli. Curr Top Microbiol Immunol 357:67–103. doi:10.1007/82_2011_176
Lingwood CA, Binnington B, Manis A, Branch DR (2010) Globotriaosyl ceramide receptor function—where membrane structure and pathology intersect. FEBS Lett 584:1879–1886. doi:10.1016/j.febslet.2009.11.089
Engedal N, Skotland T, Torgersen ML, Sandvig K (2011) Shiga toxin and its use in targeted cancer therapy and imaging. Microb Biotechnol 4:32–46. doi:10.1111/j.1751-7915.2010.00180.x
Nathanson S, Kwon T, Elmaleh M, Charbit M, Launay EA et al (2010) Acute neurological involvement in diarrhea-associated hemolytic uremic syndrome. Clin J Am Soc Nephrol 5:1218–1228. doi:10.2215/CJN.08921209
Sandvig K, Bergan J, Dyve A-B, Skotland T, Torgersen ML (2010) Endocytosis and retrograde transport of Shiga toxin. Toxicon 56:1181–1185. doi:10.1016/j.toxicon.2009.11.021
Sandvig K, Garred O, Prydz K, Kozlov JV, Hansen SH et al (1992) Retrograde transport of endocytosed Shiga toxin to the endoplasmic reticulum. Nature 358:510–512. doi:10.1038/358510a0
Spooner RA, Lord JM (2012) How ricin and Shiga toxin reach the cytosol of target cells: retrotranslocation from the endoplasmic reticulum. Curr Top Microbiol Immunol 357:19–40. doi:10.1007/82_2011_154
Tumer NE, Li X-P (2012) Interaction of ricin and Shiga toxins with ribosomes. Curr Top Microbiol Immunol 357:1–18. doi:10.1007/82_2011_174
Tesh VL (2010) Induction of apoptosis by Shiga toxins. Future Microbiol 5:431–453. doi:10.2217/fmb.10.4
Arab S, Lingwood CA (1996) Influence of phospholipid chain length on verotoxin/globotriaosyl ceramide binding in model membranes: comparison of a supported bilayer film and liposomes. Glycoconj J 13:159–166. doi:10.1007/BF00731490
Lingwood D, Binnington B, Róg T, Vattulainen I, Grzybek M et al (2011) Cholesterol modulates glycolipid conformation and receptor activity. Nat Chem Biol 7:260–262. doi:10.1038/nchembio.551
Mahfoud R, Manis A, Binnington B, Ackerley C, Lingwood CA (2010) A major fraction of glycosphingolipids in model and cellular cholesterol-containing membranes is undetectable by their binding proteins. J Biol Chem 285:36049–36059. doi:10.1074/jbc.M110.110189
Yahi N, Aulas A, Fantini J (2010) How cholesterol constrains glycolipid conformation for optimal recognition of Alzheimer’s beta amyloid peptide (Abeta1-40). Plos One 5:e9079. doi:10.1371/journal.pone.0009079
Katagiri YU, Mori T, Nakajima H, Katagiri C, Taguchi T et al (1999) Activation of Src family kinase yes induced by Shiga toxin binding to globotriaosyl ceramide (Gb3/CD77) in low density, detergent-insoluble microdomains. J Biol Chem 274:35278–35282. doi:10.1074/jbc.274.49.35278
Mori T, Kiyokawa N, Katagiri YU, Taguchi T, Suzuki T et al (2000) Globotriaosyl ceramide (CD77/Gb3) in the glycolipid-enriched membrane domain participates in B-cell receptor-mediated apoptosis by regulating lyn kinase activity in human B cells. Exp Hematol 28:1260–1268. doi:10.1016/S0301-472X(00)00538-5
Takenouchi H, Kiyokawa N, Taguchi T, Matsui J, Katagiri YU et al (2004) Shiga toxin binding to globotriaosyl ceramide induces intracellular signals that mediate cytoskeleton remodeling in human renal carcinoma-derived cells. J Cell Sci 117:3911–3922. doi:10.1242/jcs.01246
Falguières T, Mallard F, Baron C, Hanau D, Lingwood C et al (2001) Targeting of Shiga toxin B-subunit to retrograde transport route in association with detergent-resistant membranes. Mol Biol Cell 12:2453–2468
Hoey DEE, Sharp L, Currie C, Lingwood CA, Gally DL et al (2003) Verotoxin 1 binding to intestinal crypt epithelial cells results in localization to lysosomes and abrogation of toxicity. Cell Microbiol 5:85–97. doi:10.1046/j.1462-5822.2003.00254.x
Tam P, Mahfoud R, Nutikka A, Khine AA, Binnington B et al (2008) Differential intracellular transport and binding of verotoxin 1 and verotoxin 2 to globotriaosylceramide-containing lipid assemblies. J Cell Physiol 216:750–763. doi:10.1002/jcp.21456
Khan F, Proulx F, Lingwood CA (2009) Detergent-resistant globotriaosyl ceramide may define verotoxin/glomeruli-restricted hemolytic uremic syndrome pathology. Kidney Int 75:1209–1216. doi:10.1038/ki.2009.7
Van Meer G, de Kroon AIPM (2011) Lipid map of the mammalian cell. J Cell Sci 124:5–8. doi:10.1242/jcs.071233
Braverman NE, Moser AB (2012) Functions of plasmalogen lipids in health and disease. Biochim Biophys Acta 1822:1442–1452. doi:10.1016/j.bbadis.2012.05.008
Nagan N, Zoeller RA (2001) Plasmalogens: biosynthesis and functions. Prog Lipid Res 40:199–229. doi:10.1016/S0163-7827(01)00003-0
Gorgas K, Teigler A, Komljenovic D, Just WW (2006) The ether lipid-deficient mouse: tracking down plasmalogen functions. Biochim Biophys Acta 1763:1511–1526. doi:10.1016/j.bbamcr.2006.08.038
Iannitti T, Palmieri B (2010) An update on the therapeutic role of alkylglycerols. Mar Drugs 8:2267–2300. doi:10.3390/md8082267
Chae K, Piantadosi C, Snyder F (1973) An alternate enzymic route for the synthesis of the alkyl analog of phosphatidic acid involving alkylglycerol. Biochem Biophys Res Commun 51:119–124. doi:10.1016/0006-291X(73)90516-0
Watschinger K, Werner ER (2013) Orphan enzymes in ether lipid metabolism. Biochimie 95:59–65. doi:10.1016/j.biochi.2012.06.027
Das AK, Holmes RD, Wilson GN, Hajra AK (1992) Dietary ether lipid incorporation into tissue plasmalogens of humans and rodents. Lipids 27:401–405. doi:10.1007/BF02536379
Schrakamp G, Schalkwijk CG, Schutgens RB, Wanders RJ, Tager JM et al (1988) Plasmalogen biosynthesis in peroxisomal disorders: fatty alcohol versus alkylglycerol precursors. J Lipid Res 29:325–334
Styger R, Wiesmann UN, Honegger UE (2002) Plasmalogen content and beta-adrenoceptor signalling in fibroblasts from patients with Zellweger syndrome. Effects of hexadecylglycerol. Biochim Biophys Acta 1585:39–43. doi:10.1016/S1388-1981(02)00320-7
Brites P, Ferreira AS, da Silva TF, Sousa VF, Malheiro AR et al (2011) Alkyl-glycerol rescues plasmalogen levels and pathology of ether-phospholipid deficient mice. Plos One 6:e28539. doi:10.1371/journal.pone.0028539
Raa H, Grimmer S, Schwudke D, Bergan J, Wälchli S et al (2009) Glycosphingolipid requirements for endosome-to-Golgi transport of Shiga toxin. Traffic 10:868–882. doi:10.1111/j.1600-0854.2009.00919.x
Bergan J, Skotland T, Sylvänne T, Simolin H, Ekroos K et al (2013) The ether lipid precursor hexadecylglycerol causes major changes in the lipidome of HEp-2 cells. Plos One 8:e75904. doi:10.1371/journal.pone.0075904
Wen SX, Teel LD, Judge NA, O’Brien AD (2006) Genetic toxoids of Shiga toxin types 1 and 2 protect mice against homologous but not heterologous toxin challenge. Vaccine 24:1142–1148. doi:10.1016/j.vaccine.2005.08.094
Kvalvaag AS, Pust S, Sundet KI, Engedal N, Simm R et al (2013) The ERM proteins ezrin and moesin regulate retrograde Shiga toxin transport. Traffic 14:839–852. doi:10.1111/tra.12077
L’Abée-Lund TM, Jørgensen HJ, O’Sullivan K, Bohlin J, Ligård G et al (2012) The highly virulent 2006 Norwegian EHEC O103:H25 outbreak strain is related to the 2011 German O104:H4 outbreak strain. Plos One 7:e31413. doi:10.1371/journal.pone.0031413
Olsnes S, Haylett T, Sandvig K (1982) The toxic lectin modeccin. Methods Enzymol 83:357–362. doi:10.1016/0076-6879(82)83030-9
Dyve AB, Bergan J, Utskarpen A, Sandvig K (2009) Sorting nexin 8 regulates endosome-to-Golgi transport. Biochem Biophys Res Commun 390:109–114. doi:10.1016/j.bbrc.2009.09.076
Torgersen ML, Wälchli S, Grimmer S, Skånland SS, Sandvig K (2007) Protein kinase Cdelta is activated by Shiga toxin and regulates its transport. J Biol Chem 282:16317–16328. doi:10.1074/jbc.M610886200
Dyve Lingelem AB, Bergan J, Sandvig K (2012) Inhibitors of intravesicular acidification protect against Shiga toxin in a pH-independent manner. Traffic 13:443–454. doi:10.1111/j.1600-0854.2011.01319.x
Grimmer S, Spilsberg B, Hanada K, Sandvig K (2006) Depletion of sphingolipids facilitates endosome to Golgi transport of ricin. Traffic 7:1243–1253. doi:10.1111/j.1600-0854.2006.00456.x
Lingwood D, Simons K (2007) Detergent resistance as a tool in membrane research. Nat Protoc 2:2159–2165. doi:10.1038/nprot.2007.294
Ekroos K, Chernushevich IV, Simons K, Shevchenko A (2002) Quantitative profiling of phospholipids by multiple precursor ion scanning on a hybrid quadrupole time-of-flight mass spectrometer. Anal Chem 74:941–949. doi:10.1021/ac015655c
Ejsing CS, Duchoslav E, Sampaio J, Simons K, Bonner R et al (2006) Automated identification and quantification of glycerophospholipid molecular species by multiple precursor ion scanning. Anal Chem 78:6202–6214. doi:10.1021/ac060545x
Jung HR, Sylvänne T, Koistinen KM, Tarasov K, Kauhanen D et al (2011) High throughput quantitative molecular lipidomics. Biochim Biophys Acta 1811:925–934. doi:10.1016/j.bbalip.2011.06.025
Merrill AH Jr, Sullards MC, Allegood JC, Kelly S, Wang E (2005) Sphingolipidomics: high-throughput, structure-specific, and quantitative analysis of sphingolipids by liquid chromatography tandem mass spectrometry. Methods 36:207–224. doi:10.1016/j.ymeth.2005.01.009
Boerlin P, McEwen SA, Boerlin-Petzold F, Wilson JB, Johnson RP et al (1999) Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans. J Clin Microbiol 37:497–503
Honke K (2013) Biosynthesis and biological function of sulfoglycolipids. Proc Jpn Acad Ser B Phys Biol Sci 89:129–138
Bigay J, Antonny B (2012) Curvature, lipid packing, and electrostatics of membrane organelles: defining cellular territories in determining specificity. Dev Cell 23:886–895. doi:10.1016/j.devcel.2012.10.009
Honsho M, Yagita Y, Kinoshita N, Fujiki Y (2008) Isolation and characterization of mutant animal cell line defective in alkyl-dihydroxyacetonephosphate synthase: localization and transport of plasmalogens to post-Golgi compartments. Biochim Biophys Acta 1783:1857–1865. doi:10.1016/j.bbamcr.2008.05.018
Pike LJ, Han X, Chung K-N, Gross RW (2002) Lipid rafts are enriched in arachidonic acid and plasmenylethanolamine and their composition is independent of caveolin-1 expression: a quantitative electrospray ionization/mass spectrometric analysis. Biochemistry 41:2075–2088. doi:10.1021/bi0156557
Munn NJ, Arnio E, Liu D, Zoeller RA, Liscum L (2003) Deficiency in ethanolamine plasmalogen leads to altered cholesterol transport. J Lipid Res 44:182–192. doi:10.1194/jlr.M200363-JLR200
Kanzawa N, Maeda Y, Ogiso H, Murakami Y, Taguchi R et al (2009) Peroxisome dependency of alkyl-containing GPI-anchor biosynthesis in the endoplasmic reticulum. Proc Natl Acad Sci USA 106:17711–17716. doi:10.1073/pnas.0904762106
Mayinger P (2012) Phosphoinositides and vesicular membrane traffic. Biochim Biophys Acta 1821:1104–1113. doi:10.1016/j.bbalip.2012.01.002
Falguières T, Römer W, Amessou M, Afonso C, Wolf C et al (2006) Functionally different pools of Shiga toxin receptor, globotriaosyl ceramide, in HeLa cells. FEBS J 273:5205–5218. doi:10.1111/j.1742-4658.2006.05516.x
Arab S, Lingwood CA (1998) Intracellular targeting of the endoplasmic reticulum/nuclear envelope by retrograde transport may determine cell hypersensitivity to verotoxin via globotriaosyl ceramide fatty acid isoform traffic. J Cell Physiol 177:646–660. doi:10.1002/(SICI)1097-4652(199812)177:4<646:AID-JCP15>3.0.CO;2-B
Sandvig K, Ryd M, Garred O, Schweda E, Holm PK et al (1994) Retrograde transport from the Golgi complex to the ER of both Shiga toxin and the nontoxic Shiga B-fragment is regulated by butyric acid and cAMP. J Cell Biol 126:53–64. doi:10.1083/jcb.126.1.53
Nishikawa K, Watanabe M, Kita E, Igai K, Omata K et al (2006) A multivalent peptide library approach identifies a novel Shiga toxin inhibitor that induces aberrant cellular transport of the toxin. FASEB J 20:2597–2599. doi:10.1096/fj.06-6572fje
Kavaliauskiene S, Nymark C-M, Bergan J, Simm R, Sylvänne T et al (2014) Cell density-induced changes in lipid composition and intracellular trafficking. Cell Mol Life Sci 71:1097–1116. doi:10.1007/s00018-013-1441-y
Gutiérrez-Martínez E, Fernández-Ulibarri I, Lázaro-Diéguez F, Johannes L, Pyne S et al (2013) Lipid phosphate phosphatase 3 participates in transport carrier formation and protein trafficking in the early secretory pathway. J Cell Sci 126:2641–2655. doi:10.1242/jcs.117705
Smith DC, Sillence DJ, Falguières T, Jarvis RM, Johannes L et al (2006) The association of Shiga-like toxin with detergent-resistant membranes is modulated by glucosylceramide and is an essential requirement in the endoplasmic reticulum for a cytotoxic effect. Mol Biol Cell 17:1375–1387. doi:10.1091/mbc.E05-11-1035
Utskarpen A, Slagsvold HH, Dyve AB, Skånland SS, Sandvig K (2007) SNX1 and SNX2 mediate retrograde transport of Shiga toxin. Biochem Biophys Res Commun 358:566–570. doi:10.1016/j.bbrc.2007.04.159
Bujny MV, Popoff V, Johannes L, Cullen PJ (2007) The retromer component sorting nexin-1 is required for efficient retrograde transport of Shiga toxin from early endosome to the trans Golgi network. J Cell Sci 120:2010–2021. doi:10.1242/jcs.003111
Van der Poel S, Wolthoorn J, van den Heuvel D, Egmond M, Groux-Degroote S et al (2011) Hyperacidification of trans-Golgi network and endo/lysosomes in melanocytes by glucosylceramide-dependent V-ATPase activity. Traffic 12:1634–1647. doi:10.1111/j.1600-0854.2011.01263.x
D’Angelo G, Polishchuk E, Di Tullio G, Santoro M, Di Campli A et al (2007) Glycosphingolipid synthesis requires FAPP2 transfer of glucosylceramide. Nature 449:62–67. doi:10.1038/nature06097
Sprong H, Degroote S, Claessens T, van Drunen J, Oorschot V et al (2001) Glycosphingolipids are required for sorting melanosomal proteins in the Golgi complex. J Cell Biol 155:369–380. doi:10.1083/jcb.200106104
Sandvig K, Skotland T, van Deurs B, Klokk TI (2013) Retrograde transport of protein toxins through the Golgi apparatus. Histochem Cell Biol 140:317–326. doi:10.1007/s00418-013-1111-z
Sandvig K, Bergan J, Kavaliauskiene S, Skotland T (2014) Lipid requirements for entry of protein toxins into cells. Prog Lipid Res 54C:1–13. doi:10.1016/j.plipres.2014.01.001
Lewkowicz P, Banasik M, Głowacka E, Lewkowicz N, Tchórzewski H (2005) Effect of high doses of shark liver oil supplementation on T cell polarization and peripheral blood polymorphonuclear cell function. Pol Merkur Lekarski 18:686–692
Bitzan M (2009) Treatment options for HUS secondary to Escherichia coli O157:H7. Kidney Int 75:S62–S66. doi:10.1038/ki.2008.624
Nishikawa K (2011) Recent progress of Shiga toxin neutralizer for treatment of infections by Shiga toxin-producing Escherichia coli. Arch Immunol Ther Exp (Warsz) 59:239–247. doi:10.1007/s00005-011-0130-5
Stechmann B, Bai S-K, Gobbo E, Lopez R, Merer G et al (2010) Inhibition of retrograde transport protects mice from lethal ricin challenge. Cell 141:231–242. doi:10.1016/j.cell.2010.01.043
Mukhopadhyay S, Linstedt AD (2012) Manganese blocks intracellular trafficking of Shiga toxin and protects against Shiga toxicosis. Science 335:332–335. doi:10.1126/science.1215930
Acknowledgments
The work performed by the Oslo group has been supported by South-Eastern Norway Regional Health Authority, The Norwegian Cancer Society, and The Research Council of Norway. We thank Anne-Grethe Myrann for technical assistance with cell experiments, and Sirpa Sutela-Tuominen for assistance with lipidomic experiments.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bergan, J., Skotland, T., Lingelem, A.B.D. et al. The ether lipid precursor hexadecylglycerol protects against Shiga toxins. Cell. Mol. Life Sci. 71, 4285–4300 (2014). https://doi.org/10.1007/s00018-014-1624-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00018-014-1624-1